0 CHECKOUT

Antibody Target, Technology & Pipeline Database: 1-Year Subscription

  • ID: 2599449
  • May 2015
  • La Merie Publishing

Subscription to La Merie Publishing’s proprietary Antibody Database provides online access to information about more than 2,400 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their

- Technology (e.g. antibody-drug conjugate, bispecific, isotype, phage display)
- Target (e.g. Her2, CD20, TNF, PD-1/PD-L1)
- Pipelines (selected by target, therapeutic area, company, technology)
- Sales (for marketed antibodies)
- R&D Phase (clinical phases, market, preclinical)
- Territory (countrywise)
- Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
- Drug Code/Name (for individual molecules)

Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antidoies on READ MORE >

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The subscription is accessed online through a secure website. You will receive a username and password via email to access your subscription. The subscription period is one year. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The subscription is accessed online through a secure website. You will receive a username and password via email to access your subscription. The subscription period is one year. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The subscription is accessed online through a secure website. You will receive a username and password via email to access your subscription. The subscription period is one year. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S